NRC Health (NASDAQ: NRC) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $549M. The Maz Rating grades it against the other companies in its sector.
NRC Health's current Maz Rating and its five factor grades are for members: log in to see them.
At $25.89, NRC Health trades at 85.2x trailing earnings and 3.8x sales, with an EV/EBITDA of 26.5. Over the last twelve months it generated about $144M of revenue and $6M of net income. It runs a gross margin of 47.9%, an operating margin of 11.1% and a net margin of 4.5%. It shows return on equity of 103.4%, return on invested capital of 9.5% and a free cash flow yield of 3.4%. On the balance sheet: a debt-to-equity ratio of -11.28 and a current ratio of 0.64. Over the past 52 weeks the share price ranged from $11.73 to $27.60, with a beta of 0.38.
NRC Health pays a dividend yielding 2.48%, with 209% of earnings paid out. Its Maz Dividend Score is 1.17 out of 5, ranked against the other dividend payers in its sector (Safety 1.03, Growth 3.63, Yield 3.83, Consistency 1.24).
1 Wall Street analyst rating covers the stock: 1 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.